Tuesday 9th August 2022
72 people have signed up for this new trial for people living with diffuse scleroderma and now this clinical study, to test a new investigational drug for use in Diffuse Scleroderma, is ready to start.
Thursday 24th June 2021
SRUK funding is playing a key role in improving how we determine the success of new treatments in clinical trials. These projects aim to better inform researchers of the impact of potential therapies, ultimately improving wellbeing and quality of life for people living with scleroderma.
Thursday 20th May 2021
20 May 2021 is World Clinical Trials Day to mark the anniversary of the first-ever trial that was conducted in 1747. Today, clinical trials are vital in determining the safety and efficacy of new treatments all over the world. But what happens in a clinical trial, and could you take part?
Tuesday 6th August 2019
The musculoskeletal features of systemic sclerosis (SSc) are a major cause of disability, causing limitations to movement and function. The study aim was to compare the effects of daily hand exercises with or without daily home wax bath hand treatment in patients with SSc.
Friday 31st May 2019
SRUK are thrilled to see the results of an investigation, undertaken by an international team of researchers and clinicians, where there has been the identification of a new internal regulator which helps to control the body’s immune response.
Friday 24th May 2019
Approximately 25% of people who live with systemic sclerosis (SSc) also develop significant pulmonary (lung) involvement within 3 years of diagnosis. Nintedanib could make a considerable difference to the lives of people with this rare and often life-threatening disease.
Friday 12th April 2019
To understand the efficacy of treatment in clinical trials, participants are normally given structured diaries as a way of recording their own observations. Almost 30 years on from these measures being developed, there are questions about whether they are still fit for purpose in today’s landscape
Tuesday 12th February 2019
Anyone can take part in a clinical trial as long as they meet the eligibility criteria. By supporting trials, you will be helping to find the best treatments possible to manage the symptoms and effects of scleroderma and Raynaud’s.
Friday 25th January 2019
Herbal remedies have been used to tackle Raynaud's symptoms for many years in Asia, where they're believed to aid circulation. A review by the College of Korean Medicine focused on evaluating the efficacy of herbal medicines such as cinnamon and dried ginger.
Monday 22nd October 2018
Skin fibrosis can be a severe and life limiting complication of scleroderma, with a dramatic impact on quality of life. It can be progressive and painful, leading to permanent ulcers and restriction of movement. Being able to limit the progression of skin fibrosis, and ultimately, reverse the effects are a key priority for SRUK and our community.
